Detailed information for compound 1774766

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 1951.37 | Formula: C64H92N20O39P6
  • H donors: 12 H acceptors: 30 LogP: -5.72 Rotable bonds: 46
    Rule of 5 violations (Lipinski): 4
  • SMILES: O[C@@H]1[C@H](OCOC(=O)C(C)(C)C)[C@H](O[C@H]1n1cnc2c1c(N)ncn2)COP(=O)(O[C@@H]1[C@H](OCOC(=O)C(C)(C)C)[C@H](O[C@H]1n1cnc2c1c(N)ncn2)COP(=O)(O[C@@H]1[C@H](OCOC(=O)C(C)(C)C)[C@H](O[C@H]1n1cnc2c1c(N)ncn2)COP(=O)(O[C@@H]1[C@H](OCOC(=O)C(C)(C)C)[C@H](O[C@H]1n1cnc2c1c(N)ncn2)COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O)O)O
  • InChi: 1S/C64H92N20O39P6/c1-61(2,3)57(86)107-25-103-38-29(115-53(37(38)85)81-21-77-49-33(81)45(65)69-17-73-49)13-111-125(93,94)119-42-39(104-26-108-58(87)62(4,5)6)30(116-54(42)82-22-78-50-34(82)46(66)70-18-74-50)14-112-126(95,96)120-43-40(105-27-109-59(88)63(7,8)9)31(117-55(43)83-23-79-51-35(83)47(67)71-19-75-51)15-113-127(97,98)121-44-41(106-28-110-60(89)64(10,11)12)32(16-114-128(99,100)123-129(101,102)122-124(90,91)92)118-56(44)84-24-80-52-36(84)48(68)72-20-76-52/h17-24,29-32,37-44,53-56,85H,13-16,25-28H2,1-12H3,(H,93,94)(H,95,96)(H,97,98)(H,99,100)(H,101,102)(H2,65,69,73)(H2,66,70,74)(H2,67,71,75)(H2,68,72,76)(H2,90,91,92)/t29-,30-,31-,32-,37-,38-,39-,40-,41-,42-,43-,44-,53-,54-,55-,56-/m1/s1
  • InChiKey: ZGZOHSWPKRSAKP-IJPNEKOLSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0005 0.0104 0.0898
Plasmodium falciparum phosphoglycerate mutase, putative 0.0005 0.0104 0.5
Loa Loa (eye worm) hypothetical protein 0.0297 1 1
Mycobacterium tuberculosis Possible hydrolase MutT1 0.0005 0.0104 0.5
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.0175 0.5875 1
Toxoplasma gondii phosphoglycerate mutase 0.0005 0.0104 0.5
Mycobacterium tuberculosis Conserved hypothetical protein 0.0005 0.0104 0.5
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.0297 1 1
Mycobacterium leprae POSSIBLE HYDROLASE MUTT1 0.0005 0.0104 0.5
Loa Loa (eye worm) hypothetical protein 0.017 0.5705 0.566
Mycobacterium leprae conserved hypothetical protein 0.0005 0.0104 0.5
Mycobacterium tuberculosis Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) 0.0005 0.0104 0.5
Mycobacterium tuberculosis Probable conserved lipoprotein LpqD 0.0005 0.0104 0.5
Toxoplasma gondii phosphoglycerate mutase family protein 0.0005 0.0104 0.5
Brugia malayi Ribonuclease 2-5A family protein 0.0036 0.1169 1
Entamoeba histolytica protein kinase, putative 0.0036 0.1169 0.1845
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein 0.0127 0.4229 0.4169
Mycobacterium leprae PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) 0.0005 0.0104 0.5
Loa Loa (eye worm) IRE protein kinase 0.0036 0.1169 0.1076
Mycobacterium ulcerans hypothetical protein 0.0175 0.5875 1
Trichomonas vaginalis serine threonine-protein kinase, putative 0.0036 0.1162 1
Toxoplasma gondii phosphoglycerate mutase PGMII 0.0005 0.0104 0.5
Mycobacterium tuberculosis Conserved protein 0.0005 0.0104 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.0292 0.983 0.9828
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.0292 0.983 0.9828
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0005 0.0104 0.0898
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0128 0.4287 0.4227
Plasmodium vivax phosphoglucomutase-2, putative 0.0005 0.0104 0.5
Mycobacterium tuberculosis Conserved protein 0.0005 0.0104 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0036 0.1162 1
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.0292 0.983 0.9828
Treponema pallidum phosphoglyceromutase 0.0005 0.0104 0.5
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0005 0.0104 0.0898
Mycobacterium tuberculosis Glucosyl-3-phosphoglycerate phosphatase GpgP 0.0005 0.0104 0.5
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0005 0.0104 0.0898
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0127 0.4229 0.4169
Mycobacterium leprae conserved hypothetical protein 0.0005 0.0104 0.5
Chlamydia trachomatis 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 0.0005 0.0104 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0292 0.983 0.9828
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0127 0.4229 0.4169
Echinococcus multilocularis serine:threonine protein kinase:endoribonuclease 0.0036 0.1169 0.1076
Loa Loa (eye worm) hypothetical protein 0.0292 0.983 0.9828
Mycobacterium leprae probable isochorismate synthase EntC 0.0005 0.0104 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0297 1 1
Mycobacterium tuberculosis Possible phosphoglycerate mutase Gpm2 (phosphoglyceromutase) (PGAM) (BPG-dependent PGAM) 0.0005 0.0104 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0297 1 1
Giardia lamblia Hypothetical protein 0.0175 0.5875 1
Entamoeba histolytica protein kinase, putative 0.0036 0.1169 0.1845
Schistosoma mansoni serine/threonine protein kinase 0.0036 0.1169 0.1076
Plasmodium vivax phosphoglycerate mutase, putative 0.0005 0.0104 0.5
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0005 0.0104 0.0898
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.0175 0.5875 1
Toxoplasma gondii phosphoglycerate mutase family protein 0.0005 0.0104 0.5
Plasmodium falciparum phosphoglucomutase-2 0.0005 0.0104 0.5
Onchocerca volvulus 0.0297 1 1
Mycobacterium leprae conserved hypothetical protein 0.0005 0.0104 0.5
Mycobacterium leprae Possible phosphoglycerate mutase 0.0005 0.0104 0.5
Toxoplasma gondii phosphoglycerate mutase family protein 0.0005 0.0104 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0005 0.0104 0.0898
Trichomonas vaginalis conserved hypothetical protein 0.0005 0.0104 0.0898
Schistosoma mansoni 6-phosphofructokinase 0.0297 1 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0297 1 1
Toxoplasma gondii phosphoglycerate mutase family protein 0.0005 0.0104 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.0297 1 1
Echinococcus granulosus serine:threonine protein kinase:endoribonuclease 0.0036 0.1169 0.1076
Mycobacterium tuberculosis PE-PGRS family protein PE_PGRS11 0.0005 0.0104 0.5
Mycobacterium leprae PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) 0.0005 0.0104 0.5
Mycobacterium leprae Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) 0.0005 0.0104 0.5
Giardia lamblia Hypothetical protein 0.0175 0.5875 1

Activities

Activity type Activity value Assay description Source Reference
EC50 (binding) = 241 nM Activation of human recombinant RNase L endonuclease activity using 6-FAM-UUA UCA AAU UCU UAU UUG CCC CAU UUU UUU GGU UUA-BHQ-1 as substrate assessed as substrate cleavage measured for 50 mins by FRET assay ChEMBL. 23810677

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.